Corline Biomedical: Directed share issue at solid terms - Redeye
Redeye comments on Corline’s directed share issue, which raises SEK23m and strengthens the shareholder base. We have adjusted our model accordingly, resulting in a slightly changed fair value range.
ANNONS
Redeye comments on Corline’s directed share issue, which raises SEK23m and strengthens the shareholder base. We have adjusted our model accordingly, resulting in a slightly changed fair value range.
